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Abstract
The infonnation obtained from a single-antibody immunoassay can be ambiguous when the identity of the analyte is
unknown and could be one of a group of compounds all having different affinities for the antibody. If we allow the possibility
of mixtures of analytes the difficulty of the situation is aggravated. However, additional infonnation can sometimes be
obtained by assaying with a n~ber of different an~bodies. We ~~nstrate a_~p~a1e f~identifying and quantifying
analytes from a group of candidates, and illustrate the application of our method with an example from the class of s-triazine
herbicides. Using a four-antibody array, correct identification and accurate quantification were usually achieved for single-
analytes samples in the low ppb range. Mixtures of analytes were recognized as such but were more difficult to classify
correctly, with some confusion arising between members of subgroups, particularly within the methoxy/methylthio substituted
triazines. The mathematical perspective is used to suggest directions for improving the experimental perfonnance of
multianalyte immunoassay.
Keywords: Immunoassay; Cross-reactivity; Muitianalyte
1. Introduction
In analytical chemistry, the identity of a compound
is not usually proven directly: rather one attempts to
disprove it under conditions of increasing rigor.
When those conditions become sufficiently rigorous
we then accept he resulting data as proof of identity.
The problem of proof extends to all aspects of
analytical chemistry, including immunoassay. Since
immunoassays are not commonly coupled to chro-
matographic systems which might separate the
compounds prior to analysis, one has the added
complexity of wanting to being able to determine
mixtures with detector systems of varying degrees of
selectivity for analytes.
The quantitative data obtained from a single
immunoassay only have a valid interpretation when
either the antibody used is monospecific for a
particular analyte or if the sample is known not to
contain any possible cross-reactants; otherwise, it is
impossible to tell whether the signal obtained is due* Corresponding author. Tel.: (+1 916) 752-7399; fax: (+1 916)
752-2924.
0003-2670/96/$15.00 @ 1996 Elsevier Science B.V. All rights reserved
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application by using a four-antibody assay for eight $-
triazine herbicides, including mixtures. Our examples
and illustrations use competitive immunoassays with
a coating hapten format [8]; the approach, however, is
general and easily adapted to other formats.
2. Response paths
First consider the case of two cross-reacting
analytes assayed with two different antibodies, with
dose-response curves as shown in Fig. 1. In the
absence of experimental error, we would know
exactly the positions of the calibration curves. Given
the responses (Y1, Y2) from an unknown sample
containing one or the other of the analytes, we could
take each candidate analyte in turn and calculate an
estimated concentration from each assay. In one case
the estimates would be consistent and, in the other,
they would not, provided that the analytes showed
different patterns of cross-reactivity to the two
antibodies. Thus we could identify the analyte as
the one which gave a consistent estimate, and this
estimate would be the true concentration. Further-
~ore, we could add more possible analytes and
~ways, pfovidedlliiit the cross-reactivity patfe"fns are
sufficiently different, correctly identify the unknown
using only two antibodies. Unfortunately experimen-
tal variation is unavoidable, so we have to pick the
analyte which gives the most consistent estimates. In
this section we consider how this consistency should
be measured, by taking into account how experi-
1.2[ Antibody 1
1
Y1
0.8 :~~~
O.6~
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to an amount of the analyte under investigation or a
different amount of some other analyte which also
has an affinity for the antibody being used. There are
many ways to address this problem including the use
of a completely different analytical system for
validation of the results or the coupling of immuno-
chemical detection methods with chromatographic
separation [1]. One could also work on the develop-
ment of antibodies which are more specific for the
analytes of interest using either monoclonal or
recombinant technology or careful hapten design'
and a collection of polyclonal antibodies. However,
the use of a library of antibodies to look at the same
group of analytes in different ways presents an
alternative solution which offers several advantages.
In case of s-triazine herbicides, for example, there
are so many possible commercial compounds that it
is not economical to make a separate immunoassay
for each compound. An array of less specific
antibodies that can recognize overlapping classes of
materials has the potential to be more efficient than a
large batch of separate assays, while retaining the
advantages of speed and low cost over conventional
systems such as GC-MS.
A number of authors have examined the possibility
of using an array of antibodies to enable identification
and quantification from within a group of similar
analytes. The general approach is discussed by
Kauvar [2]. Cheung et al. [3] demonstrate the use
of some multivariate statistical methods in analyzing
the responses from several antibodies. Karu et al. [4]
give an overview and evaluation of various statistical
approaches. Wortberg et al. [5] describe the con-
struction and application of an immunoarray in the
case of s-triazine herbicides. The preceding deal
chiefly with single-analyte samples. Analysis of
mixtures of cross-reacting analytes, when the identity
of each analyte in the mixture is known, has been
demonstrated by Muldoon et al. [6]. A model for such
mixture analysis was proposed by Jones et al. [7] and
implemented successfully for mixtures of two, three
or four analytes [8].
We describe below an assay procedure for samples
which might contain one or more of a class of cross-
reacting analytes, combining the work by earlier
authors on pattern recognition and mixture analysis.
First, we present a mathematical and statistical
rationale for our procedure. Then we illustrate its~
01"-:
0.0001 0.01
Fig. 1. Responses (optical densities) of two cross-reacting analytes
to two different antibodies. The identity of a single-analyte
unknown with responses (fl. f2) is that which gives a consistent
concentration estimate X.
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sample point. However, the metric for measuring the
distance needs to be chosen appropriately using a
statistical model, so that the likelihood of the various
possibilities can be evaluated. It may be that the
sample point is so far from both response paths that
either single analyte is unlikely; in such cases one
would suspect a mixture.
Clearly this method will not be reliable for very
small or very large concentrations, since here the
response paths are close together: one would only be
able to ascertain that one had a very small (or very
large) concentration of something. Thus, there will be
a workable range for the assay (as with single-
antibody assays) within which reasonably reliable
identification and quantification should be possible.
This will depend in part on how far apart the two
response paths are, which in turn depends on how
different the patterns of cross-reactivity are to the
antibodies used.
In practice, we are likely to have more than two
analytes in a cross-reacting group, and to require
more than two antibodies. We now develop a
statistical model for the general case of n antibodies.
mental error impinges on the estimated concentra-
tions. The situation becomes clearer if we represent
the assay responses in another fashion.
The two response curves from a single analyte
(Fig. 1) can be combined into a single response path
as follows: for a given concentration x of Analyte 1
we can read off from the curves the responses (Y1, Y2)
and plot them as a single point in two-dimensional
space (see Fig. 2). By varying x from 0 to 00 we get
the complete response path, given parametrically by
the concentration x. This is then repeated for Analyte
2, as shown in Fig. 2. Note that, here, we are
assuming common horizontal asymptotes for the two
curves from each assay (since they will be jointly
estimated from the same microtiter plate), so the
response paths begin and end together. Whereas this
is a reasonable assumption for competitive assays, it
may not be true in general, so that the response paths
may not be joined. The overall approach taken here
will still be valid, although details of the implementa-
tion will change.
Now suppose we have the responses (Y1, Y2) from
an unknown single-analyte sample. In the absence of
experimental error, this point would have to lie on
one or other of the response paths, thus identifying
the analyte and enabling quantification. In practice,
the point may lie between the two curves, as in Fig. 2;
intuitively one would pick the curve nearest the
3. The statistical model
We model the individual dose-response cw:ves for
single-analyte samples using the four-parameter
logistic model [9]. We assume further that the
coefficient of variation of the responses Y from an
individual assay is constant, so that log Y has a
constant standard deviation. There are more sophis-
ticated and flexible ways of incorporating hetero-
scedasticity [10], but these further complicate the
methodology and we have found the log transforma-
tion to be adequate. Thus our model is
log Yj = log
+f
i= n
Fig. 2. Response paths for two cross-reacting analytes assayed
with two antibodies. Co-ordinates are the responses (optical
density) of a given analyte concentration to each antibody. The
unknown marked "X" would be classified as Analyte 2 or, if the
distance was too great, a mixture.
where Yi is the assay response from antibody i, x the
analyte concentration, Ai, Bi, Ci, Di the model
parameters and fi an error assumed to have a normal
distribution with zero mean and standard deviation O"i.
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sample were indeed Analyte 2, would be less than
0.01, and we would probably conclude that it was not
Analyte 2. If both distances were improbably large,
we could next consider the possibility of a mixture.
Here, Aj and Dj represent, respectively, the assay
response at zero and infinite analyte concentration, Cj
the ICso (the concentration giving 50% inhibition),
and Bj a slope parameter.
The values of A, B, C, D and 0" wouldl, in fact, be
estimated by a.ssaying a set of standard concentra-
tions along with the unknowns. We assume here that
this estimation is precise, so that the parameter values
are known. It is convenient now to write
4. Mixture analysis
The possibility of a multi-analyte sample can be
explored using the extended four-parameter logistic
model of Jones et al. [7]. The response Y; from a
binary mixture of analytes with concentrations (XI.
X2) is modeled by
log Yj = fi(x) + fj, (2)
where/;(x) is a known function as given in Eq. (1). By
assumption, lo!~ Yi is normally distributed with mean
/;(x) and standard deviation O"i, so we no1;\' find that
log Yj -j;(x) (3)
O'j
which represents the error distance in terms of
multiples of its standard deviation, follows a standard
normal distribultion. Since the assays wiith different
antibodies can be regarded as statistically indepen-
dent these vaIiables are independent for each i.
Statistical theoJ'Y then suggests ([11], p.177) that
d2 = t (~~-=~)21"./ 2i=1 O"i Xnl (4)
i.e. the quantit:f d2 as defined here shotJlld follow a
known distribution: the chi-square distribilltion with n
degrees of freel:lom. Furthermore, d can be regarded
as a distance in n-dimensional space. If iJ[1 Fig. 2, we
re-scale each aJus by taking logs and diviiding by the
estimated 0", then d becomes the ordin~y Euclidean
distance betwet~n the sample point and tile curve.
The true va]lue x is, in fact, not-known, so we
estimate it by the value X which gives the closest
distance to the curve. This is found analytically by
minimizing ovt~r x the expression for d2 in Eq. (4).
The resulting minimum distance should approxi-
mately follow it X~-l distribution (ont~ degree of
freedom is lost because of the estimation of x). Thus
tabulated values of the chi-square distribution can be
used to decide if the distance from the sample point
to a given response path is improbably large. For
example, if the distance from the sample point to
Analyte 2 in Fig. 2 gave d=7.0, tables (xi) tell us that
the probability of obtaining such a re:sult, if the
where Aj, Bij, Cij, Dj are the parameters of the
calibration curve for analyte.; with antibody i, and Bj*
is the geometric mean of Bjll and Bj2'
If we use two antibodies, we solve a pair of non-
linear simultaneous equations for the estimation of
(Xl, X2); if there are more 1:han two antibodies, we
choose (Xl, X2) to minimize ~ of Eq. (4), with fi(x)
replaced by !,{XI, X2) as in I~. (5). As before, if we
are using the correct pair of analytes for a given
sample, d2 will follow a c::hi-squared distribution.
Since we are now estimating two extra parameters, Xl
and X2, the appropriate distribution will be X~-2'
Our proposed analysis, h~lving obtained estimates
of the curve parameters usin~~ standard concentrations
of all analytes in the group.. is to first calculate the
distance from a sample point to each of the single-
analyte response paths. If allY of these are plausible
when referred to the appropriate chi-square distribu-
tion, the corresponding analyte and concentration are
considered as plausible determinations of the un-
known sample (there may be more than one plausible
analyte within the group). If all single analytes give
implausible answers, we search all possible binary
combinations until a set of plausible solutions is
found.
In practice this may produce several possibilities
for the composition of the unknown sample, but these
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will be ranked in order of plausibility by their d2
value. Strict adherence to the maximum likelihood
principle ([11], p.254) would suggest that we accept
the solution with the smallest d2, but it is important to
be aware of other close alternatives. It may therefore
be worthwhile proceeding with the binary mixture
analysis even if we obtain a satisfactory solution at
the first stage. One could go a stage further and
examine possible ternary mixtures, but without a
large number of discriminating antibodies this is
likely to produce a confused picture since there may
be many acceptable combinations of analytes. Further
refinement of the experimental procedure, particu-
larly in the careful choice of suitable antibodies, will
be necessary for the successful analysis of complex
mixtures.
sample there are three decisions to be made: is the
unknown a single analyte or a mixture, which
analytes are present, and at what concentrations?
5.1. Single analyte
5. Examples
We now illustrate and evaluate this method of
analysis using single analytes and binary mixtures
chosen from the class of s-triazine herbicides and
their metabolites (see Fig. 3). For each unknown
CI
NaNJ..N~Nl.l-N-
H H
Atrazine
"azines"
CI
NAN
""'-Nl..QJ-N,,",-
H H
Simazine
Here, we re-analyze the data given in Wortberg et
at. [5]. Standard curves were obtained for prometon,
atrazine, simazine, cyanazine, hydroxyatrazine, pro-
metryn, terbutryn and deethylatrazine on a single
microtiter plate, together with fourteen unknown
samples in duplicate (see Fig. 4). Four such plates
were treated with four different antibodies: AM7B2.1
[12], KIF4 [13], #2652 [14] and #4653 [15]. This
was repeated with another set of four plates using
different unknowns, thus giving a total of 28
unknown samples to be determined. The unknowns
were all single analytes at concentrations of 0.75, 1.5
or 5 ppb, excepting two samples per plate which were
negative controls. A full description of the assay
procedure is given in Wortberg et at. [5].
In the analysis, we first assume a single analyte and
calculate the minimum distance to each of the eight
response paths, using F.q. (4). These distances are
referred to a X~ distribution (e.g. the 95th percentage
~t is 7".81) for assessing their likelihood.For.~
example, one sample contained simazine at 5 ppb.
The results for this sample are shown in Table 1. The
only acceptable possibility is that the sample contains
simazine, and the estimated concentration of 4.65 ppb
turns out to be quite accurate.
A less successful example is given by the sample
containing 0.75 ppb terbutryn. The results are shown
CI
ACN NON+N~N~N-
H H
Cyanazine
metabolites of "a;~ines"
OH CI
NaN NaN
AN~N~N"" AN~N~NHH H H 2
Hydroxyatrazine Deethyiatrazine
"tryns/tons"
SCH3
NaNAN~Ndl.NA
H H
Prometryn
SCH3
NaN+N~N!lNA
H H
Terbutryn
OCH3
NAN
AN-lyJ.NJ..
H H
Prometon
Fig. 4. Template for the first experiment showing locations of
standards (Sxx) and unknowns (Uxx).Fig. 3. Some of the s-triazines and their metabolites.
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Table I
Results for a sample containing 5 ppb simazine. d2=squared
distance from the sample response to the response path of the
assumed analyte; p=probability of getting ~ as large as this
assuming a X~ distribution
Table 3
Summary of results from assaying 24 single-analyte samples.
showing whether the correct single analyte was chosen (based on
lowest ~). whether the d2 statistic was acceptably low (at 5%
significance level) and whether assumption of a binary mixture
gave significant improvement.
Correct identity Incorrect identityPrometon
Atrazine
Simazine
Cyanazine
Ohatrazine
Prometryn
Terbutryn
Deatrazine
173.99
10.39
2.11
15.93
233.87
166.80
166.72
233.80
<0.0001
0.0155
0.5500
0.0012
<0.0001
<0.0001
<0.0001
<0.0001
Acceptable ~ too high Acceptable ~ too high
Add 2nd No 10
Analyte Yes-
2
7
3
1
Table 2
Results for a sample containing 0.75 ppb terbutryn. All of the ~
values seem improbably large, so we would next try a binary
mixture analysis
was causing a false positive. Spatial trends can
sometimes be observed on microplate data [16],
variously ascribed to inhomogeneity of the plate
material, temperature gradients, misalignment of the
plate reader and other effects.
A summary of the results for the 24 positive
samples is given in Table 3, showing whether the
correct analyte was identified at the first stage,
whether the distance statistic at this stage was
acceptably small, and whether this could be improved
using binary mixture analysis. Out of the 24 samples,
19 succeeded in identifying the correct analyte at the
first stage, but in nine of those cases the distance from
the model,~,was unaccepmblylarge and in seven of
those the addition of a second analyte (i.e. a binary
mixture) gave a significant improvement in fit. Four
of the five incorrect identifications arose from
confusion between prometon, prometryne and terbu-
tryn. The fifth was actually 0.75 ppb simazine, and
the ~ value of 4.19 was acceptable for simazine but a
better fit was achieved by assuming cyanazine
(d2=2.60).
16.99
67.79
88.82
137.96
162.17
13.93
15.97
155.43
0.0007
<0.0001
<0.0001
<0.0001
<0.0001
0.0030
0.0012
«}.OOOI
in Table 2. None of the single-analyte possibilities is
really acceptable, and the distances for prometon,
prometryn and terbutryn are similar. (The difficulty of
distinguishing between these three with this array of
antibodies was noted by Wortberg et al. [5]). We now
search through all possible binary combinations, and
find that the fit can be improved significantly by
including a small amount of hydroxyatrazine,
although the resulting distance is still rather large.
Our conclusion would probably be that the sample
contains either prometon, prometryn or terbutryn,
with perhaps a small amount of hydroxyatrazine. The
estimate for hydroxyatrazine in the mixture analysis
was 0.05 pbb, a seemingly negligible amount, but the
antibody here, #4653, was extremely sensitive to
hydroxyatrazine (ICso=O.l ppb), enough to reduce the
d2 value from 15.97 to 7.64. Close examination of the
data revealed that a few adjacent samples had the
same characteristic of wanting to add hydroxyatra-
line; apparently, a spatial effect on one of the plates
5.2. Binary mixtures
The goal here was to identify and quantify binary
mixtures of triazine herbicides out of a pool of eight
possibile candidates. These herbicides were atrazine,
simazine, cyanazine, prometryn, prometon, terbutryn
and the two atrazine metabolites hydroxyatrazine and
deisopropylatrazine. For this experiment, we used the
antibodies AM7B2.1, K1F4, #4652 [15] and #2282
[17]. The plate template and the general assay
procedure were as in the single-analyte experiment
above. Again two sets of plates were used, giving a
total of 28 unknown samples to be determined. All
G. Jones et al./Analytica Chimica Acta 336 (1996) 175-183 181
If!
~
""
'--
'--
"S
--2C!
.o~
Co
Co
Q)
c:
.~
E
tnln
ci
~1,\\
-2:5
~{ "4
0.0 0.5 1.0 1.5
F'rometon ppb
Fig. 5. Contour plot of log(~) for a sample containing I ppb
simazine and Ippb prometon, assuming a binary mixture of
simazine and prometon.
Table 5
Summary of results from assaying 25 binary mixtures showing the
outcome and whether the ~ statistic was acceptably low
Acceptable
~ too high
0
0
were binary mixtures of 1 ppb of each of two
analytes, except for two negative controls and one
sample of 1 ppb atrazine only.
Analysis procceeded as above, first assuming a
single analyte and comparing the d2's with a X~
distribution, then, if this assumption proved unten-
able, assuming a binary mixture and comparing
with X~. We illustrate here with the results from
a sample containing 1 ppb simazine and 1 ppb
prometon. Single-analyte analysis gave the shortest
distance to any of the response paths as 29.7, which,
when referred to X~, has a probability less than
0.00001. Mixture analysis indicates three possible
binary mixtures (with acceptably small d1 as
shown in Table 4. The rather high estimate for
deisopropylatrazine reflects the lower sensitivity to
this analyte in our chosen array of antibodies. We
would probably conclude that the unknown contained
either atrazine and prometon or simazine and
prometon. We can illustrate the uncertainty in the
estimated concentrations by calculating d2 over an
array of values near the estimates and drawing a
contour plot as in Fig. 5. The use of such plots for
producing confidence regions for the estimates is
under investigation.
A summary of.th~-~~~_oL~-@~Y.§i~__Qf th~- 25
mixtures is given in Table 5. As noted by Wortberg
et al. [5], the analytes tend to fall i:l1to groups with
respect to their cross-reactivities: the chloro-s-
triazines (atrazine, simazine, cyana2:ine), the meth-
oxy/methylthio-s-triazines (prometon, prometryn
and terbutryn) and hydroxymetabolites (hydroxy a-
trazine). The dealkylated chloro-s-tri:azine (deisopro-
pylatrazine) was relatively unreacti'fe with all our
antibodies but tended to behave like the first
group, and its presence was often masked by the
other analytes. As the overall results show, the assay
was quite successful at indicating the correct group
or groups, but less successful at distinguishing
between possible combinations within groups. Thus,
for example, a mixture of atrazine and prometryn
was identified as cyanazine and prometon, or possibly
cyanazine and terbutryn. A mixture of prometon
and terbutryn appeared to contain terbutryn only.
The estimated concentrations using the correct
identities were reasonably accurate, whether or
not this was identified as one of the possible
answers.
Table 4
Results for binary mixture analysis of a samI,le containing I ppb
simazine and I ppb prometon. Only three as~;umed mixtures are
shown; the other 25 combinations gave p-valul~s less than 0.0007.
6. Discussion
d2 We have illustrated a methodology for immunoa-
nalysis of samples which might contain one or
more from a group of cross-reacting analytes. One
obvious application is in cases where a complete
set of monospecific antibodies for each of the
analytes does not exist. However, this approach
p
Atrazine
Simazine
Diatrazine
Prometon
Prometon
Prometon
0.42
0.67
12.76
2.05
3.53
5.94
0.36
0.17
0.05
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might be useful even when there are monospecific
antibodies available. If samples could be placed
into groups using a small number of antibodies
with significant cross-reactivities, and individual
members of each group could then be identified
using a smaller number of more specific antibodies,
then the resulting assay procedure could generally
use less antibodies and, hence, be more efficient. We
could thus have a hierarchical system starting with a
single screening assay, then a multipll~ assay for
positive samples sorting them into groups, and a final
assay for each group to distinguish between its
members.
Our results suggest that the method has potential,
but we are still far from reliable iderutification in
every case. Further difficulties could be expected in
applying the method to mixtures of more than two
analytes, or binary mixtures in which one component
was at a much higher concentration than the other.
Although some success has already been achieved in
this area in cases where the number of candidate
analytes is small [8], the difficulty is compounded
here by having a large number of possible candidates.
In the present situation, our particular an1:ibody array
lacked the power to discriminate between certain
combinations of analytes and we now CO]tlS~~r__SQm~~~
reasons for this.
Firstly, the pattern of cross-reactivities has to be
sufficiently different for each analyte. We have noted
the difficulty in separating prometon, prometryn and
terbutryn: this occurs because they all had similar
cross-reactivity patterns across the antibociies. We are
developing antibodies with more dis.criminatory
power which should increase the utillity of our
approach.
Secondly, ranges of sensitivity were diifferent. For
example, in the first assay the lowe:;t ICso for
deethylatrazine was 12 ppb: for hydroxyatrazine it
was 0.1 ppb. The assay could perhaps be improved by
decreasing the sensitivity of some of the assays to get
a similar dynamic range to each anal)'te. Another and
possibly preferable solution would be: to use a
dilution series for each unknown.
Thirdly, the size of experimental error (coefficient
of variation) can be crucial for multi-anal:yte analysis.
If the individual assays are not very precise this
can seriously degrade the performaI1Ce of the
multiple assay. We have noted above a problem
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with spatial effects, which have the potential to give
rise to very misleading conclusions (see also [16]).
Precision could be greatly improved if spatial
variations could be eliminated. Another factor
contributing to low precision is the limited space
available on the microtiter plate, so that there has to
be a small number of standards for the calibration
curves, and few replicates of each unknown. A
possible solution is to use separate plates as
suggested by Jones et al. [18]. Analytical chemists
can certainly encourage manufacturers to work in
these directions. As we look into the future of
immunoassay technology it is likely that we will see
miniaturized imrnunoassays which among other
things will allow more replicates of each assay and
many assays to be run on a single plate (see [19]).
This will certainly increase precision as computer
averaging systems have done in other branches of
analytical chemistry such as mass spectrophotometry
[20].
Finally, the assumptions made in deriving the
distribution of the minimum d2 statistic were
probably not valid for our data, particularly our
assumption that the curve parameters A, B, C, D and
a are precisely estimated. l'his would explain why
QY!:h~~_s~i~_w:~~~etimes too_t~ge.~~.Qf
separate plates, enabling more standards to be used
for each curve, might improve this; otherwise a more
complicated statistical argument would be required.
We are currently investigating all of the above
possibilities, and hope that some of these approaches
can be extended more generally to assist in the
interpretation of results from a variety of methods in
multi-analyte analysis.
G. Jones et al./Analytica Chimica Acta 336 (1996) 175...183
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